🟠 Moderate Evidence
Cancer and chronic illnesses profoundly disrupt sexual function and intimacy, yet most healthcare systems fail to address these concerns as part of routine clinical care. According to a comprehensive review published in Nature Reviews Disease Primers (2026), sexual health problems are a direct consequence of both disease and treatment, yet remain inadequately managed in clinical practice due to provider discomfort, insufficient training, and persistent societal taboo around discussing sexuality in medical settings.
Key takeaways
- Sexual dysfunction is a direct consequence of cancer and chronic disease treatments, yet remains systematically under-addressed in routine clinical care
- Clinician training gaps and societal stigma around sexual health discussions create barriers to assessment and intervention
- A biopsychosocial model integrating sexual health screening and support into whole-person cancer and chronic illness care is clinically necessary and evidence-supported
- Sexual health is a recognized component of quality of life and overall wellbeing, with implications for treatment adherence and psychological outcomes
Review at a Glance
| Source | Nature Reviews Disease Primers |
| Publication type | Comprehensive clinical review |
| Focus | Sexual health integration in cancer and chronic illness care |
| Model | Biopsychosocial approach to sexual wellbeing |
| Published | June 2026 |
The Clinical Gap: Sexual Health in Oncology and Chronic Disease Care
Barriers to sexual health integration across the care pathway
Source: Nature Reviews Disease Primers (2026) | Georgian Medical Journal News
Disease and treatment directly damage sexual function
Cancer diagnoses and their treatments—chemotherapy, radiation, surgery, and hormone therapy—cause direct physiological damage to sexual function across multiple pathways. According to the Nature Reviews Disease Primers analysis, these mechanisms include vascular dysfunction, hormonal disruption, nerve damage, and anatomical changes that impair arousal, orgasm, and satisfaction. Chronic illnesses including cardiovascular disease, diabetes, arthritis, and neurological conditions similarly compromise sexual response through both disease pathology and medication side effects.
Beyond physiology, the psychological impact is equally profound. Cancer diagnosis triggers anxiety, depression, body image distortion, and loss of identity—all documented correlates of sexual dysfunction. The review emphasizes that sexual problems are not merely side effects to be tolerated; they represent a significant and treatable dimension of illness burden that directly affects quality of life, intimate relationships, and psychological wellbeing.
Clinician discomfort and training gaps perpetuate silence
Despite the clinical significance, healthcare providers across oncology and chronic disease specialties frequently avoid assessing and addressing sexual health concerns. According to the Nature Reviews Disease Primers review, this avoidance stems from multiple intersecting factors: insufficient training in sexual health assessment during medical education, lack of clinical confidence in discussing sexuality, discomfort with the topic due to personal or cultural beliefs, and absence of standardized screening protocols in routine practice.
The training gap is particularly acute. Most oncology and internal medicine residency programs provide minimal or no structured education in sexual health assessment, counselling, or referral pathways. This leaves clinicians ill-equipped to recognize sexual problems, initiate conversations, or connect patients to appropriate resources. The result is a pervasive clinical silence: patients with untreated sexual dysfunction suffer in isolation, often unaware that evidence-based interventions exist. A clinical updates review on sexual medicine integration underscores that brief training interventions significantly improve provider comfort and screening rates.
Societal taboo reinforces clinical avoidance
Beyond provider training deficits, cultural stigma around sexuality in healthcare settings creates mutual barriers. Patients often hesitate to initiate conversations about sexual problems, particularly in conservative healthcare settings or with opposite-sex providers. According to the Nature Reviews Disease Primers analysis, this reluctance is reinforced by perceptions that sexuality is not a legitimate medical concern, that discussing it is inappropriate in a clinical encounter, or that nothing can be done. Clinicians, in turn, may interpret patient silence as disinterest rather than embarrassment, further perpetuating non-assessment.
This bidirectional silence has measurable consequences. Studies cited in the review document that the majority of cancer and chronic illness patients with sexual dysfunction never discuss the issue with their oncologist or primary care physician. Patients instead suffer privately, experience relationship strain, and may abandon cancer treatment or medication adherence due to unaddressed sexual side effects. The psychological burden of untreated sexual dysfunction intersects with cancer-related distress and chronic illness depression, amplifying mental health risks.
Biopsychosocial integration offers a practical clinical framework
The Nature Reviews Disease Primers review advocates for systematic integration of sexual health assessment and management into routine oncology and chronic disease care using a biopsychosocial model. This framework recognizes that sexual function is not purely physiological but depends on biological health (disease and medication effects), psychological wellbeing (mood, body image, relationship satisfaction), and social context (partner availability, cultural norms, access to resources). Effective sexual health care requires coordinated intervention across all three domains.
Practical implementation begins with routine, normalized screening using validated brief instruments such as the Sexual Activity Questionnaire or the International Index of Erectile Function. According to the review, integrating a single open-ended question—”Has your illness or treatment affected your sexual health or intimate relationships?”—into standard patient encounters dramatically increases disclosure rates and allows clinicians to triage appropriately. Patients with identified sexual concerns should be offered education about expected treatment effects, reassurance that sexual problems are treatable, and referral to appropriate specialists: sex therapists, urologists, gynecologists, or sexual medicine specialists depending on the specific problem.
Psychological interventions including cognitive-behavioral therapy, couples counseling, and mindfulness-based approaches address the emotional and relational dimensions of sexual dysfunction. Pharmacological and device-based interventions (phosphodiesterase-5 inhibitors, vaginal moisturizers, vibrators, penile implants, or clitoral suction devices) target physiological impairment. The evidence base for these interventions is substantial, yet access remains limited in most healthcare settings due to lack of awareness, training, and systems integration.
Sexual health is a recognized component of overall wellbeing and quality of life, yet remains systematically under-addressed in cancer and chronic illness care due to clinician training gaps, societal taboo, and absence of integrated screening and referral pathways. A biopsychosocial model incorporating routine assessment, patient education, and coordinated specialist referral is both clinically necessary and evidence-supported.
— Nature Reviews Disease Primers (2026)
What this means
Frequently asked questions
Why is sexual health often ignored in cancer and chronic illness care?
According to the Nature Reviews Disease Primers review, sexual health is overlooked due to three overlapping barriers: (1) inadequate clinician training in sexual health assessment and intervention, (2) cultural and institutional taboo around discussing sexuality in medical settings, and (3) absence of standardized screening protocols and quality measures. Most medical education provides minimal training in sexual medicine, leaving clinicians uncomfortable initiating these conversations.
What are the main ways cancer treatment damages sexual function?
Cancer treatments cause sexual dysfunction through multiple mechanisms documented in the review: chemotherapy and radiation induce vascular dysfunction and hormonal disruption affecting arousal; surgery may cause anatomical changes or nerve damage; hormone therapy suppresses testosterone or estrogen; and radiation fibrosis can impair genital blood flow and elasticity. Beyond physiology, cancer diagnosis triggers anxiety, depression, and body image distortion that further impair sexual response.
What evidence-based treatments exist for sexual dysfunction in cancer survivors?
The review identifies multiple evidence-based approaches: psychological interventions (cognitive-behavioral therapy, couples counseling, mindfulness); pharmacological treatments (phosphodiesterase-5 inhibitors for erectile dysfunction, hormone replacement therapy where appropriate); device-based therapies (vibrators, penile implants, clitoral suction devices); and vaginal treatments (moisturizers, dilators, topical hormones). Effectiveness improves when physical, psychological, and relational dimensions are addressed in coordinated, multimodal care.
Integrating sexual health into cancer and chronic illness care represents a fundamental shift toward whole-person medicine. As healthcare systems increasingly recognize that quality of life encompasses intimate relationships and sexual wellbeing, institutional change will require concurrent efforts: investment in clinician training, normalization of sexual health screening in clinical protocols, expansion of specialist capacity, and removal of insurance and social barriers to evidence-based sexual medicine. The science is clear; the clinical framework is established. What remains is systematic implementation.
Source: Integrating sexual health into care for patients with cancer and chronic illness, Nature Reviews Disease Primers (June 2026)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
